By Sandy Lunoe, VacTruth
Judging by the huge amount of publicity around vaccine promotion many are under the impression that the manufacturers know all about their products in detail. It may be shocking to discover that this is far from the truth.
Here are some examples of what Merck the manufacturer does not know about Gardasil:
1. Whether Gardasil prevents cancer
Gardasil is promoted as a vaccine which prevents cancer. Here is what immunologist Charlotte Haug M.D. Ph.D writes in her article in New Scientist (1)
“Despite claims that the vaccine will cut cancer deaths by two-thirds or more, its overall effectiveness in the prevention of cervical cancer remains unknown and will not be known for decades.”
2. Necessity for boosters
Information regarding the possible necessity and intervals for booster doses is unknown.
3. Whether Gardasil increases the risk of cancer.
The vaccine has not been evaluated for the potential to cause carcinogenicity(2). Absence of evidence is not evidence of absence!
There may be increased risk of cancer due to replacement of some virus strains with new strains which may be more carcinogenic.
“If HPV-16 and HPV-18 are effectively suppressed, will there be selective pressure on the remaining strains of HPV? Other strains may emerge as significant oncogenic serotypes” (3)
Rosemary Mathis, director of SaneVax asks:” Gardasil and Cervarix: Are strains targeted by the vaccines replaced by other HPV viruses?”(4)
4. Whether there is increased risk of cancer due to the unexpected discovery of aluminium bound recombinant HPV DNA
Dr. Sin Hang Lee, a pathologist at the Milford Hospital pathology laboratory was contracted by SaneVax to examine Gardasil for possible contamination. The samples tested positive for recombinant viral HPV-11 and viral HPV-18 residues, both of which were firmly attached to the aluminum adjuvant (5)
It is unknown whether the recombinant (genetically engineered) HPV DNA is capable of altering human DNA potentially initiating cancer (5)
5. Whether there is increased risk of autoimmune disorders due to the recombinant HPV DNA
It is unknown whether the genetically engineered HPV DNA, or adventitious DNA, is capable of altering human DNA potentially initiating a host of autoimmune disorders (5)